Adebola Emmanuel Orimadegun

Adebola Emmanuel Orimadegun

Auto-generated profile, based on publicly available information

Adebola Emmanuel Orimadegun

University of Ibadan

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
AMAmy McMillan
Amy McMillan
JRJustin B. Renaud
Justin B. Renaud
KBKevin M.N. Burgess
Kevin M.N. Burgess
AOAdebola E. Orimadegun
Adebola E. Orimadegun
OAOlusegun O. Akinyinka
Olusegun O. Akinyinka
MSMark W Sumarah
Mark W Sumarah

1 August 2018 in The Lancet Haematology
Verified
Journal Article
Open access
CNCarolyne M Ndila
Carolyne M Ndila
SUSophie Uyoga
Sophie Uyoga
AMAlexander W Macharia
Alexander W Macharia
GNGideon Nyutu
Gideon Nyutu
NPNorbert Peshu
Norbert Peshu
LYLawrence Yamoah
Lawrence Yamoah
Human genetic factors are important determinants of malaria risk. We investigated associations between multiple candidate polymorphisms-many related to the structure or function of red blood cells-and risk for severe Plasmodium falciparum malaria and its specific phenotypes, including cerebral malaria, severe malaria anaemia, and respiratory distress. We did a case-control study in Kilifi County, Kenya. We recruited as cases children presenting with severe malaria to the high-dependency ward of Kilifi County Hospital. We included as controls infants born in the local community between Aug 1, 2006, and Sept 30, 2010, who were part of a genetics study. We tested for associations between a range of candidate malaria-protective genes and risk for severe malaria and its specific phenotypes. We used a permutation approach to account for multiple comparisons between polymorphisms and severe malaria. We judged p values less than 0·005 significant for the primary analysis of the association between candidate genes and severe malaria. Between June 11, 1995, and June 12, 2008, 2244 children with severe malaria were recruited to the study, and 3949 infants were included as controls. Overall, 263 (12%) of 2244 children with severe malaria died in hospital, including 196 (16%) of 1233 with cerebral malaria. We investigated 121 polymorphisms in 70 candidate severe malaria-associated genes. We found significant associations between risk for severe malaria overall and polymorphisms in 15 genes or locations, of which most were related to red blood cells: ABO, ATP2B4, ARL14, CD40LG, FREM3, INPP4B, G6PD, HBA (both HBA1 and HBA2), HBB, IL10, LPHN2 (also known as ADGRL2), LOC727982, RPS6KL1, CAND1, and GNAS. Combined, these genetic associations accounted for 5·2% of the variance in risk for developing severe malaria among individuals in the general population. We confirmed established associations between severe malaria and sickle-cell trait (odds ratio [OR] 0·15, 95% CI 0·11-0·20; p=2·61 × 10-58), blood group O (0·74, 0·66-0·82; p=6·26 × 10-8), and -α3·7-thalassaemia (0·83, 0·76-0·90; p=2·06 × 10-6). We also found strong associations between overall risk of severe malaria and polymorphisms in both ATP2B4 (OR 0·76, 95% CI 0·63-0·92; p=0·001) and FREM3 (0·64, 0·53-0·79; p=3·18 × 10-14). The association with FREM3 could be accounted for by linkage disequilibrium with a complex structural mutation within the glycophorin gene region (comprising GYPA, GYPB, and GYPE) that encodes for the rare Dantu blood group antigen. Heterozygosity for Dantu was associated with risk for severe malaria (OR 0·57, 95% CI 0·49-0·68; p=3·22 × 10-11), as was homozygosity (0·26, 0·11-0·62; p=0·002). Both ATP2B4 and the Dantu blood group antigen are associated with the structure and function of red blood cells. ATP2B4 codes for plasma membrane calcium-transporting ATPase 4 (the major calcium pump on red blood cells) and the glycophorins are ligands for parasites to invade red blood cells. Future work should aim at uncovering the mechanisms by which these polymorphisms can result in severe malaria protection and investigate the implications of these associations for wider health. Wellcome Trust, UK Medical Research Council, European Union, and Foundation for the National Institutes of Health as part of the Bill & Melinda Gates Grand Challenges in Global Health Initiative.

1 July 2020 in OTO Open
Verified
Journal Article
Open access
PDF file
TITitus Sunday Ibekwe
Titus Sunday Ibekwe
AFAyotunde James Fasunla
Ayotunde James Fasunla
AOAdebola Emmanuel Orimadegun
Adebola Emmanuel Orimadegun
Objective: Loss of smell and taste are considered potential discriminatory symptoms indicating triaging for coronavirus disease 2019 (COVID‐19) and early case identification. However, the estimated prevalence essential to guide public health policy varies in published literature. This meta‐analysis aimed to estimate prevalence of smell and taste loss among COVID‐19 patients.Data Sources: We conducted systematic searches of PubMed, Embase, Web of Science, and Google Scholar databases for studies published on the prevalence of smell and taste loss in COVID‐19 patients.Review Methods: Two authors extracted data on study characteristics and the prevalence of smell and taste loss. Random‐effects modeling was used to estimate pooled prevalence. Subgroup analysis and meta‐regression were conducted to explore potential heterogeneity sources. This study used PRISMA and MOOSE guidelines.Results: Twenty‐seven of 32 studies reported a prevalence of loss of smell, taste, or both from a combined sample of 20,451 COVID‐19 patients. The estimated global pooled prevalence of loss of smell among 19,424 COVID‐19 patients from 27 studies was 48.47% (95% CI, 33.78%‐63.29%). Loss of taste was reported in 20 studies and 8001 patients with an estimated pooled prevalence of 41.47% (95% CI, 3.13%‐31.03%), while 13 studies that reported combined loss of smell and taste in 5977 COVID‐19 patients indicated a pooled prevalence of 35.04% (95% CI, 22.03%‐49.26%).Conclusions: The prevalence of smell and taste loss among COVID‐19 patients was high globally, and regional differences supported the relevance of these symptoms as important markers. Health workers must consider them as suspicion indices for empirical diagnosis of severe acute respiratory syndrome coronavirus 2 infection.

1 January 2022 in International Journal for Parasitology
Verified
Journal Article
Closed access
MAMuhydeen Abiodun Abdulraheem
Muhydeen Abiodun Abdulraheem
MEMedard Ernest
Medard Ernest
IUIfeoma Ugwuanyi
Ifeoma Ugwuanyi
HAHussein M. Abkallo
Hussein M. Abkallo
SNSaori Nishikawa
Saori Nishikawa
RCRichard Culleton
Richard Culleton

17 April 2014 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JBJulie Bachmann
Julie Bachmann
FBFlorence Burté
Florence Burté
SPSetia Pramana
Setia Pramana
ICIanina Conte
Ianina Conte
BBBiobele J. Brown
Biobele J. Brown
PNPeter Nilsson
Peter Nilsson
Systemic inflammation and sequestration of parasitized erythrocytes are central processes in the pathophysiology of severe Plasmodium falciparum childhood malaria. However, it is still not understood why some children are more at risks to develop malaria complications than others. To identify human proteins in plasma related to childhood malaria syndromes, multiplex antibody suspension bead arrays were employed. Out of the 1,015 proteins analyzed in plasma from more than 700 children, 41 differed between malaria infected children and community controls, whereas 13 discriminated uncomplicated malaria from severe malaria syndromes. Markers of oxidative stress were found related to severe malaria anemia while markers of endothelial activation, platelet adhesion and muscular damage were identified in relation to children with cerebral malaria. These findings suggest the presence of generalized vascular inflammation, vascular wall modulations, activation of endothelium and unbalanced glucose metabolism in severe malaria. The increased levels of specific muscle proteins in plasma implicate potential muscle damage and microvasculature lesions during the course of cerebral malaria. Why do some malaria-infected children develop severe and lethal forms of the disease, while others only have mild forms? In order to try to find potential answers or clues to this question, we have here analyzed more than 1,000 different human proteins in the blood of more than 500 malaria-infected children from Ibadan in Nigeria, a holoendemic malaria region. We identified several proteins that were present at higher levels in the blood from the children that developed severe malaria in comparison to those that did not. Some of the most interesting identified proteins were muscle specific proteins, which indicate that damaged muscles could be a discriminatory pathologic event in cerebral malaria compared to other malaria cases. These findings will hopefully lead to an increased understanding of the disease and may contribute to the development of clinical algorithms that could predict which children are more at risks to severe malaria. This in turn will be of high value in the management of these children in already overloaded tertiary-care health facilities in urban large densely-populated sub-Saharan cities with holoendemic malaria such as in the case of Ibadan and Lagos.

11 April 2013 in Blood
Verified
Journal Article
Open access
PDF file
FBFlorence Burté
Florence Burté
BBBiobele J. Brown
Biobele J. Brown
AOAdebola E. Orimadegun
Adebola E. Orimadegun
WAWasiu A. Ajetunmobi
Wasiu A. Ajetunmobi
NANathaniel K. Afolabi
Nathaniel K. Afolabi
DFDelmiro Fernandez-Reyes
Delmiro Fernandez-Reyes
Key Points: Hepcidin rises more dramatically in mild malaria than in severe malaria. Hepcidin levels are linked to inflammation, not anemia, in severe malarial anemia and cerebral malaria.